In a statement on Tuesday, Lilly said it stands "firmly behind our advertising." The company also said the "gold standard for comparing medicines is a robustly designed, well-conducted head-to-head clinical trial," such as the one it uses in its ad campaigns to compare its obesity injection, Zepbound, to Wegovy
What records does the article suggest gathering before a consultation about semaglutide
Regular monitoring may be needed to track your response to treatment
248 GLP-1 can effectively bind to receptors on -cells, stimulating the secretion of somatostatin
Annals of the New York Academy of Sciences, 965(1), 466-477
However, its important to assess potential interactions and side effects when combining these peptides to ensure safety and effectiveness